1. Home
  2. SWKH vs TKNO Comparison

SWKH vs TKNO Comparison

Compare SWKH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$17.25

Market Cap

205.9M

Sector

Finance

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$2.27

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWKH
TKNO
Founded
1996
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.9M
214.1M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
SWKH
TKNO
Price
$17.25
$2.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
5.3K
323.6K
Earning Date
03-18-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
N/A
EPS
1.85
N/A
Revenue
$40,149,000.00
$39,801,000.00
Revenue This Year
$52.93
$8.64
Revenue Next Year
N/A
$9.73
P/E Ratio
$9.31
N/A
Revenue Growth
62.38
9.50
52 Week Low
$13.17
$2.16
52 Week High
$20.49
$9.98

Technical Indicators

Market Signals
Indicator
SWKH
TKNO
Relative Strength Index (RSI) N/A 17.84
Support Level N/A $2.17
Resistance Level N/A $2.50
Average True Range (ATR) 0.00 0.26
MACD 0.00 -0.07
Stochastic Oscillator 0.00 10.47

Price Performance

Historical Comparison
SWKH
TKNO

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: